TY - JOUR
T1 - Pnictogens in medicinal chemistry
T2 - evolution from erstwhile drugs to emerging layered photonic nanomedicine
AU - Liu, Chuang
AU - Shin, Jinwoo
AU - Son, Subin
AU - Choe, Youmi
AU - Farokhzad, Nika
AU - Tang, Zhongmin
AU - Xiao, Yufen
AU - Kong, Na
AU - Xie, Tian
AU - Kim, Jong Seung
AU - Tao, Wei
N1 - Funding Information:
This study is supported by the US METAvivor Early Career Investigator Award (Grant No. 2018A020560; to W. T.), Harvard Medical School/Brigham and Women’s Hospital Department of Anesthesiology Basic Scientist Grant (Grant No. 2420 BPA075; to W. T.), Khoury Innovation Award (Grant No. 2020A003219; to W. T.), The Gillian Reny Stepping Strong Center for Trauma Innovation Breakthrough Innovator Award (Grant No. 113548; to W. T.), American Heart Association Collaborative Science Award (No. 2018A004190; to W. T.), National Natural Science Foundation of China (Grant No. 81730108 and Grant No. 81973635; to T. X.), and a CRI project of the National Research Foundation of Korea (Grant No. 2018R1A3B1052702, to J. S. K.). W. T. also received a start-up package (for 3 years) from the Department of Anesthesiology, Perioperative and Pain Medicine to establish his independent research laboratory at Harvard Medical School and Brigham and Women’s Hospital. We thank our department for this generous support. C. L. acknowledges the scholarship provided by the University of Chinese Academy of Sciences (UCAS) for his joint PhD study in Prof. Tao’s team.
Funding Information:
This study is supported by the US METAvivor Early Career Investigator Award (Grant No. 2018A020560; to W. T.), Harvard Medical School/Brigham and Women's Hospital Department of Anesthesiology Basic Scientist Grant (Grant No. 2420 BPA075; to W. T.), Khoury Innovation Award (Grant No. 2020A003219; to W. T.), The Gillian Reny Stepping Strong Center for Trauma Innovation Breakthrough Innovator Award (Grant No. 113548; to W. T.), American Heart Association Collaborative Science Award (No. 2018A004190; to W. T.), National Natural Science Foundation of China (Grant No. 81730108 and Grant No. 81973635; to T. X.), and a CRI project of the National Research Foundation of Korea (Grant No. 2018R1A3B1052702, to J. S. K.). W. T. also received a start-up package (for 3 years) from the Department of Anesthesiology, Perioperative and Pain Medicine to establish his independent research laboratory at Harvard Medical School and Brigham and Women’s Hospital. We thank our department for this generous support. C. L. acknowledges the scholarship provided by the University of Chinese Academy of Sciences (UCAS) for his joint PhD study in Prof. Tao's team.
Publisher Copyright:
© The Royal Society of Chemistry 2020.
PY - 2021/2/21
Y1 - 2021/2/21
N2 - Pnictogens (the non-metal phosphorus, metalloids arsenic and antimony, and metal bismuth) possess diverse chemical characteristics that support the formation of extended molecular structures. As witnessed by the centuries-old (and ongoing) clinical utilities, pnictogen-based compounds have secured their places in history as “magic bullet” therapeutic drugs in medicinal contexts. Moreover, with the development of recent metalloproteomics and bio-coordination chemistry, the pnictogen-based drugs functionally binding to proteins/enzymes in biological systems have been underlaid for “drug repurposing” with promising opportunities. Furthermore, advances in the modern materials science and nonotechnology have stimulated a revolution in other newly discovered forms of pnictogens—phosphorene, arsenene, antimonene, and bismuthine (layered pnictogens). Based on their favorable optoelectronic properties, layered pnictogens have shown dramatic superiority as emerging photonic nanomedicines for the treatment of various diseases. This tutorial review outlines the history and mechanism of action of ancient pnictogen-based drugs (e.g., arsenical compounds in traditional Chinese medicine) and their repurposing into modern therapeutics. Then, the revolutionary use of emerging layered pnictogens as photonic nanomedicines, alongside assessments of theirin vivobiosafety, is discussed. Finally, the challenges to further development of pnictogens are set forth and insights for further exploration of their appealing properties are offered. This tutorial review may also provide some deep insights into the fields of integrated traditional Chinese and Western medicines from the perspective of materials science and nanotechnology.
AB - Pnictogens (the non-metal phosphorus, metalloids arsenic and antimony, and metal bismuth) possess diverse chemical characteristics that support the formation of extended molecular structures. As witnessed by the centuries-old (and ongoing) clinical utilities, pnictogen-based compounds have secured their places in history as “magic bullet” therapeutic drugs in medicinal contexts. Moreover, with the development of recent metalloproteomics and bio-coordination chemistry, the pnictogen-based drugs functionally binding to proteins/enzymes in biological systems have been underlaid for “drug repurposing” with promising opportunities. Furthermore, advances in the modern materials science and nonotechnology have stimulated a revolution in other newly discovered forms of pnictogens—phosphorene, arsenene, antimonene, and bismuthine (layered pnictogens). Based on their favorable optoelectronic properties, layered pnictogens have shown dramatic superiority as emerging photonic nanomedicines for the treatment of various diseases. This tutorial review outlines the history and mechanism of action of ancient pnictogen-based drugs (e.g., arsenical compounds in traditional Chinese medicine) and their repurposing into modern therapeutics. Then, the revolutionary use of emerging layered pnictogens as photonic nanomedicines, alongside assessments of theirin vivobiosafety, is discussed. Finally, the challenges to further development of pnictogens are set forth and insights for further exploration of their appealing properties are offered. This tutorial review may also provide some deep insights into the fields of integrated traditional Chinese and Western medicines from the perspective of materials science and nanotechnology.
UR - http://www.scopus.com/inward/record.url?scp=85101274192&partnerID=8YFLogxK
U2 - 10.1039/d0cs01175d
DO - 10.1039/d0cs01175d
M3 - Review article
C2 - 33367452
AN - SCOPUS:85101274192
SN - 0306-0012
VL - 50
SP - 2260
EP - 2279
JO - Chemical Society Reviews
JF - Chemical Society Reviews
IS - 4
ER -